Tilia Fiduciary Partners’s GSK GSK Stock Holding History

Tilia Fiduciary Partners’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-36	Closed	-$1.28K	–	244
2023 Q2	$1.28K	Hold	36	–	–	﹤0.01%	492
2023 Q1	$1.28K	Hold	36	–	–	﹤0.01%	478
2022 Q4	$1.26K	Hold	36	–	–	﹤0.01%	472
2022 Q3	$1K	Hold	36	–	–	﹤0.01%	495
2022 Q2	$2K	Hold	36	–	–	﹤0.01%	493
2022 Q1	$2K	Hold	36	–	–	﹤0.01%	503
2021 Q4	$2K	Buy	+36	New	+$1.87K	﹤0.01%	525

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Tilia Fiduciary Partners's GSK Position: Q3 2023 in Review

Tilia Fiduciary Partners sold out of GSK (GSK) in Q3 2023, closing a stake of 36 shares — an estimated $1.28K sold.

Tilia Fiduciary Partners first reported a position in GSK in Q4 2021 and held it in 7 quarters. The position peaked at $2K in Q2 2022. 847 funds tracked by Wall St. Rank hold GSK as of Q3 2023.

Tilia Fiduciary Partners reported no remaining GSK position as of Q3 2023 after selling out during the quarter.
Tilia Fiduciary Partners sold 36 GSK shares in Q3 2023, an estimated $1.28K.
Tilia Fiduciary Partners first reported a position in GSK in Q4 2021 and held it in 7 quarters.
Tilia Fiduciary Partners's GSK position peaked at $2K in Q2 2022.
847 funds tracked by Wall St. Rank held GSK as of Q3 2023.

Based on Tilia Fiduciary Partners's 13F filing for Q3 2023, filed 10 Oct 2023.